About
Technology
Issues
FAQ
Links
Official Page
Advances of CD19-directed chimeric antigen receptor-modified T cells in refractory/relapsed acute lymphoblastic leukemia
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.
